6986 Stock Overview
HeXun Biosciences Co., Ltd. engages in the research and development of stem cell and treatments in Taiwan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
HeXun Biosciences Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$63.10 |
| 52 Week High | NT$99.00 |
| 52 Week Low | NT$40.00 |
| Beta | 0 |
| 1 Month Change | 14.73% |
| 3 Month Change | 5.70% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -30.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6986 | TW Life Sciences | TW Market | |
|---|---|---|---|
| 7D | -7.1% | -0.2% | -2.3% |
| 1Y | n/a | -24.0% | 27.2% |
Return vs Industry: Insufficient data to determine how 6986 performed against the TW Life Sciences industry.
Return vs Market: Insufficient data to determine how 6986 performed against the TW Market.
Price Volatility
| 6986 volatility | |
|---|---|
| 6986 Average Weekly Movement | 10.8% |
| Life Sciences Industry Average Movement | 5.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 6986's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 6986's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | n/a | www.hexunbio.com |
HeXun Biosciences Co., Ltd. engages in the research and development of stem cell and treatments in Taiwan. It provides outsourced production services; commissioned development and manufacturing services for various cells and cell derivatives; commissioned inspection; advisory; laboratory information management system; and sterile filling services. The company was founded in 2019 and is based in Taoyuan City, Taiwan.
HeXun Biosciences Co., Ltd. Fundamentals Summary
| 6986 fundamental statistics | |
|---|---|
| Market cap | NT$2.90b |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 6986 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6986 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 6986 perform over the long term?
See historical performance and comparison